S
Sabrina Bakeera-Kitaka
Researcher at Makerere University
Publications - 3
Citations - 240
Sabrina Bakeera-Kitaka is an academic researcher from Makerere University. The author has contributed to research in topics: Viral load & Lamivudine. The author has an hindex of 3, co-authored 3 publications receiving 234 citations. Previous affiliations of Sabrina Bakeera-Kitaka include University of Minnesota.
Papers
More filters
Journal ArticleDOI
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.
Moses R. Kamya,Harriet Mayanja-Kizza,Andrew Kambugu,Sabrina Bakeera-Kitaka,Fred C. Semitala,Patricia Mwebaze-Songa,Barbara Castelnuovo,Petra Schaefer,Lisa A. Spacek,Anne Gasasira,Elly Katabira,Robert Colebunders,Thomas C. Quinn,Allan R. Ronald,David L. Thomas,Adeodata Kekitiinwa +15 more
TL;DR: In this article, the authors identified predictors of viral failure and documented genotypic mutations in a subset of patients with viral failure after 12 months on antiretroviral therapy (ART).
Journal ArticleDOI
Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy
Sabrina Bakeera-Kitaka,Sabrina Bakeera-Kitaka,Anali Conesa-Botella,Aggrey Dhabangi,Albert Maganda,Addy Kekitiinwa,Robert Colebunders,David R. Boulware +7 more
TL;DR: After TB screening was instituted in 2006, the proportion of new TB cases diagnosed after starting ART decreased by 70% (95%CI 51-82, P < 0.001), abating the early excess risk.
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy
Moses R. Kamya,Harriet Mayanja-Kizza,Andrew Kambugu,Sabrina Bakeera-Kitaka,Fred C. Semitala,Patricia Mwebaze-Songa,Barbara Castelnuovo,Petra Schaefer,Lisa A. Spacek,Anne Gasasira,Elly Katabira,Robert Colebunders,Thomas C. Quinn,Allan R. Ronald,David L. Thomas,Adeodata Kekitiinwa +15 more
TL;DR: In this paper, the authors identified predictors of viral failure and documented genotypic mutations in a subset of patients with viral failure after 12 months on antiretroviral therapy (ART).